Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment

PLoS ONE(2021)10.1371/journal.pone.0225869Source: DataRank Database

A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.30)OA: goldTopics (63)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Marco Tomasetti ORCID,Sekar T. Verapazham,Ramasamy Paulmurugan ORCID,X. Cynthia ORCID,Sandeep Rajput ORCID

Live enrichment

PubMed:33556062 PMC:PMC7870153 OpenAlex:https://openalex.org/W3126981642

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Grant: CA183353

NCI NIH HHS

Grant: R43 CA183353

National Institutes of Health

Grant: 1R43CA183353-01

Dual Targeted Human Beta Defensin for Improving Chemotherapy

FWCI

0.30

Citation Percentile

0.5%

Citation Trend

2021

2023

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0225869&type=printable

GREENhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0225869&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0225869&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0225869

journalhttps://doi.org/10.1371/journal.pone.0225869

Fields of Study

Cell death mechanisms and regulationRetinoids in leukemia and cellular processesCancer-related Molecular PathwaysBiologyMedicine03 medical and health sciences0302 clinical medicine

MeSH Terms

A549 CellsPC-3 CellsAnimalsAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinDrug Screening Assays, AntitumorDrug SynergismHumansMice, NudeNeoplasm Recurrence, LocalNeoplasmsNeoplastic Stem CellsApoptosisPaclitaxelDrug Resistance, NeoplasmXenograft Model Antitumor AssaysTocopherolsCell Line, TumorCell ProliferationMiceMCF-7 Cells

Keywords

ApoptosisCancer researchCancerCancer treatmentSignal transductionMedicineBioinformaticsBiologyCell biologyInternal medicineGeneticsPaclitaxelScience610Mice, NudeTocopherolsMiceAntineoplastic combined chemotherapy protocolsCell Line, TumorNeoplasmsAnimalsHumansCell ProliferationNeoplastic stem cellsQRDrug SynergismA549 CellsDoxorubicinDrug Resistance, NeoplasmPC-3 CellsMCF-7 CellsDrug Screening Assays, AntitumorNeoplasm Recurrence, LocalResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being